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Abstract
The molecular determinants of abnormal propagation of action potentials along axons and ectopic conductance in
demyelinating diseases of the central nervous system, like multiple sclerosis (MS), are poorly defined. Widespread
interruption of myelin occurs in several mouse models of demyelination, rendering them useful for research. Herein,
considerable myelin loss is shown in the optic nerves of cuprizone-treated demyelinating mice. Immuno-fluorescence
confocal analysis of the expression and distribution of voltage-activated K+ channels (KV1.1 and 1.2 a subunits) revealed
their spread from typical juxta-paranodal (JXP) sites to nodes in demyelinated axons, albeit with a disproportionate increase
in the level of KV1.1 subunit. Functionally, in contrast to monophasic compound action potentials (CAPs) recorded in
controls, responses derived from optic nerves of cuprizone-treated mice displayed initial synchronous waveform followed
by a dispersed component. Partial restoration of CAPs by broad spectrum (4-aminopyridine) or KV1.1-subunit selective
(dendrotoxin K) blockers of K+ currents suggest enhanced KV1.1-mediated conductance in the demyelinated optic nerve.
Biophysical profiling of K+ currents mediated by recombinant channels comprised of different KV1.1 and 1.2 stoichiometries
revealed that the enrichment of KV1 channels KV1.1 subunit endows a decrease in the voltage threshold and accelerates the
activation kinetics. Together with the morphometric data, these findings provide important clues to a molecular basis for
temporal dispersion of CAPs and reduced excitability of demyelinated optic nerves, which could be of potential relevance to
the patho-physiology of MS and related disorders.
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Introduction
Multiple sclerosis (MS) is a polyfactorial, devastating disease of
the central nervous system (CNS). Despite being recognized almost
two centuries ago, it remains the number one cause of non-
traumatic neurological conditions in young adults [1,2], with no
radical treatment available. Throughout its protracted course,
alternating deficits of axonal functions associated with demyelin-
ation deteriorates into conduction failure and progressive axonal
degeneration, culminating in partial or complete sensory and
motor incapacitation.
Functional and developmental studies have indicated essential
roles for myelin in the rapid conduction of action potentials along
thick myelinated axons [3,4]. Enveloping neurites in a highly
compartmented manner, myelin provides an effective shield
essential for saltatory propagation of action potentials. There is
considerable but conflicting evidence suggesting a stabilizing
influence of voltage-activated KV1 currents on the excitability
and conductivity of central and peripheral axons [5,6,7]. Mediated
through channels produced by tetramerization of KV1.1 with 1.2
(and to a lesser extent 1.6) a subunits, and normally concentrated
at the juxta-paranodes (JXPs), KV1 channels spread to internodes
and nodal segments upon demyelination, causing impedance
mismatch and disruption of action potential conduction [8,9,10].
Accordingly, indiscriminate pharmacological inhibition of K+
currents has been shown to restore the electrogenic functions of
demyelinated axons, a mechanism that is implicated in some of the
ameliorative influence of 4-aminopyridine (4-AP) and its analogues
in MS patients [11,12]. However, emerging evidence from animal
studies suggests that the beneficial effects of therapeutically-
relevant concentrations of 4-AP on axonal physiology are due to its
action as a synaptic transmission enhancer [12,13]. Indeed, low
mM concentrations of 4-AP and 3,4-di-aminopyridine greatly
facilitate neurotransmission at both excitatory and inhibitory
synapses in the central and peripheral nervous systems [14,15]. Of
note, several studies also assigned therapeutic effects of 4-AP to its
inhibition of immune cell proliferation [12,16]. Inevitably, such
broad-spectrum effects hampers the utilisation of 4-AP for
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discriminatory restoration of the functionality of demyelinated
axons without off target effects.
A prevalence of optic neuropathies with functional disruptions
during early MS [17,18] kindled our interest in analysing the
importance of KV1 currents in regulating electrophysiological
properties of the optic nerve (ON) in a cuprizone-induced model
of demyelination [19]. Our data demonstrate that demyelination is
associated with an increase in K+ conductance mediated by
ectopically expressed KV1 channels enriched with the KV1.1 a
subunit. Evidence is presented for disruptive effects of KV1.1 on
ON electrophysiology, and its critical influence on the biophysical
and pharmacological profiles of KV1 currents in a heterologous
expression system, signifying the pertinence of Kv1.1 subunit to
conductive aberrations in demyelinating axons.
Materials and Methods
Animals and Induction of Demyelination
C57BL/6J male mice (8 weeks old) were obtained from Harlan
(UK) and housed (2162 uC, humidity 3662% at 12/12-h light/
dark cycle) in the Bio-Resource Unit of Dublin City University
with food and water provided ad libitum. All procedures were
approved by the University Ethics Committee, and licensed by the
Department of Children and Health (Rep. of Ireland) in
accordance with European Communities Council Directive of
24 November 1986 (86/609/ECC). Special efforts were made to
minimize animal suffering and reduce the number of animals used.
All animals received a Modified LabDietH, with 0.2% cuprizone
(Sigma, MO) supplemented to chow of the experimental
(cuprizone treated) mice for 8 weeks, a time sufficient for induction
of demyelination [19].
Measurement of the Myelin Content in Brain Samples
Myelin was purified by sucrose density gradient centrifugation
[20]. In brief, after decapitation of anaesthetized mice (sodium
pentobarbital 200 mg/kg, i.p.), brains were dissected out,
weighed, frozen in liquid N2 and stored at -80 uC till used. The
tissue was homogenized in 0.25 M sucrose/phosphate buffer
saline (PBS, pH 7.4) and centrifuged for 10 min at 5006 g, 4uC;
after re-centrifugation of the supernatant (10 min at 100006 g),
the resultant pellet was re-suspended in 10 volumes of the buffered
0.25 M sucrose. Following addition of an equal volume of 0.88 M
sucrose and centrifugation (3 h at 1000006 g), myelin was
collected at the interface between the two sucrose layers. Then,
it was re-suspended in 10 volumes of ice-cold de-ionized water and
re-centrifuged (150006g for 30 min, 4uC); this step was repeated
4 times to remove the residual sucrose, with the final pellet being
dried and weighed.
Histochemistry and Transmission Electron Microscopy
Control and experimental mice (16 weeks old) were anaesthe-
tized as above, perfused intra-cardially with PBS (pH 7.4) followed
by fixation with 4% para-formaldehyde (PFA; Sigma, Ireland) in
PBS, as described [21]. The brains were post-fixed overnight in
PFA (4uC), cryo-protected (30% sucrose in PBS, 4uC for 24 h) and
sectioned in mid sagittal plain (30 mm) followed by staining with
luxol fast blue (LFB) or cresyl violet (CV) (n = 3 in each group),
using protocols specified elsewhere [22,23]. Sections were
mounted, air-dried, immersed in xylene, and coverslipped with
DPX mounting medium (Sigma, Ireland) and imaged using light
microscope (Axioscope, Zeiss, Germany) with a DP72 colour
camera (Olympus). For densitometry, colour images were
converted into black and white, followed by analysis using
intensity macro on randomly-defined regions of interests (ROI)
in specified areas (ImageJ, NIH, USA).
For electron microscopy, perfusion of the mice was carried out
according to the protocol [24] but with 1.5% glutaraldehyde in
0.1 M phosphate buffer (pH 7.2). After careful removal from the
cranial cavity, ON was kept overnight in this fixative solution
(4uC), post-fixed by 1% OsO4 for 2 h, and dehydrated. The
quality of fixation and gross morphology of ON were assessed with
toluidine staining of cross-sections (15 mm) while the rest of the
tissue was immersed in graded alcohol and embedded in Epon
resin. Ultra-thin sections (2 mm) were cut and contrasted with
uranyl acetate/lead citrate, before being imaged with an FEI
Tecnai-12 electron microscope (Tecnai FEI, Nanoport, Oregon,
USA). The ‘g’ ratio or myelination index was estimated as the ratio
of inner axonal diameter (d) to the outer diameter (D) of the ON
fibres (g = d/D).
Immuno-cytochemistry and Confocal Microscopy
Fixed ON embedded in Tissue Tack was frozen, sliced
longitudinally (10 mm) (Leica CM3050S, Germany) and permea-
bilized (0.1% Triton X-100 in PBS) for 6 h (21uC) followed by
blocking for 2 h with 10% goat serum [GS in PBS containing 5%
bovine serum albumin (BSA) and 0.1% Triton X-100]. For
KV1.1/1.2 double-staining, the primary anti-KV1.2 antibody
(mouse monoclonal; NeuroMab, USA) was applied at 1:500
dilution for 24 h (4uC) in 2% GS, 5% BSA, 0.1% Triton X-100 in
PBS. After rinsing in PBS (3620 min), sections were incubated
overnight (4uC) with goat anti-mouse Alexa-568 fluor-labelled
secondary antibody (Invitrogen, 1:500) followed by washes
(3620 min) and 12 h exposure to anti-KV1.1 (rabbit polyclonal;
Alomone Lab., Jerusalem). After 3 rinses, sections were incubated
for 12 h in goat anti-rabbit-Alexa-488 flour labelled secondary
antibodies (Invitrogen, 1:1500), washed extensively, mounted and
covered with Vectashield (Vector Labs, UK) for microscopic
analysis. Specificities of the immuno-staining procedures were
verified in negative controls, with omission of the primary
antibodies. For NaV/KV1.2 staining, longitudinal cryosections
(10 mm) of ON were placed on superfrost slides, blocked for 3 h
with 10% horse serum containing 0.1% Triton X-100 (in PBS).
Both polyclonal Nav and monoclonal Kv1.2 antibodies at dilutions
of 1:50 and 1:200, respectively, were added for 24 h at room
temperature, followed by 3 rinses. Subsequently, the tissue was
incubated with biotinylated anti-mouse and -rabbit antibodies
(Vector lab, 1:1000) sequentially for 45 min each and developed
with its corresponding streptavidin tagged flourophore (1:1000,
Alexa-488 and -568-labeled, Invitrogen) for 45 min, washed and
mounted with Vectasheild for fluorescence microscopy. Field
micrographs were obtained (206objective) using a laser scanning
microscope in epifluorescence mode (pinhole wide open) (Ax-
ioObserver, Carl Zeiss; Germany), while high-magnification
images of JXPs were acquired in confocal mode (pinhole = 0.5AU,
406 objective) for analysis. Argon and Helium/Neon lasers
provided the 488 and 568 nm lines for excitation; emitted signals
were sampled in a frame mode at spatial resolution of 30 nm per
pixel with 1.5 ms dwell time. The mean fluorescence intensities,
fluorescent areas and co-localization of labelled KV1.1 and 1.2 a
subunits were quantified with ImageJ and Zen 2008 (Carl Zeiss,
Germany).
CAP Recordings from ON and Pharmacological Analysis
Mice (16–17 weeks old) were decapitated under deep anaes-
thesia (as above) and ON carefully transected in proximity to the
sphenoid canal. Brain with attached ON was removed and
immersed for 5 min in bubbled (95% O2, 5% CO2) ice-cold
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solution containing (in mM): sucrose, 75; NaCl, 85; KCl, 2.5;
NaH2PO4, 1.25; NaHCO3, 25; CaCl2, 0.5; MgCl2 4; glucose, 25,
pH 7.3 and glued in the recording chamber attached to the stage
of an upright Olympus BX51WI microscope with the ON facing
upward. The sample was perfused continuously throughout the
experiment with bubbled (95% O2, 5% CO2) artificial cerebro-
spinal fluid (aCSF) containing (in mM): NaCl, 125; KCl, 3;
NaH2PO4, 1.25; NaHCO3, 25; CaCl2, 2; MgCl2, 2; glucose, 25;
pH 7.3 at 33–35uC. The perinervium was carefully removed with
the distal end of the ON drawn into a suction electrode for
stimulation. Evoked CAP recordings were made with low-
resistance glass pipettes (5–15 mm tip diameter, 0.2–1.2 MV) filled
with aCSF, which was gently inserted into the ON at close
proximity to the optical chiasm to record evoked CAPs (stim.
100 ms pulse; 1.0–1.5 mA/0.03 Hz). Efforts were made to keep
relatively constant the distance between the stimulation and
recording electrodes at 1.0–1.2 mm. Unlike the complex shape
CAP recordings of ON (Allen et al., 2006) using a suction
electrode at room temperature, under our settings the CAP with
glass pipette from control mice revealed a simple waveform,
attributing the differences in the shapes CAP to: (1) smaller pool of
axons contributing to the CAPs recorded with glass pipette (2)
shorter distance between the stimulation and recordings sites with
less temporal dispersion of the action potentials from population of
heterogeneous axons and (3) use of temperatures close to
physiological in the present study. Analog signals were acquired
in episodic mode, amplified (EPC-10 USB controlled by Patch-
master 2.20; HEKA Instruments) and filtered at 10 kHz before
storage for off-line analysis (Clampfit 10.0; Molecular Devices,
CA). For measurement of the CAP refractory period, paired
stimuli of sub-maximal intensity (1/2 max amplitude) were applied
at various inter-pulse intervals, and the peak amplitude ratio of the
second vs. the first (A2/A1) response was plotted as a function of
the inter-stimulus intervals. Peptide blockers were aliquoted in
recording solution, stored at 220uC and added to the perfusion
medium before use. Dendrotoxin K (DTXK) was purified in-
house; tityustoxin-Ka (TsTX-Ka) was obtained from Peptide
International (Kentucky, USA). Tetraethylammonium chloride
(TEA) and 4-AP were purchased from Sigma (Wicklow, Ireland)
and Lancaster Synthesis (Lancaster, UK), respectively.
Heterologous Expression and Characterization of
Concatenated KV1 Channels
KV1.1 or 1.2 asubunit genes were concatenated and expressed
as homo-tetramers KV(1.1)4 or KV(1.2)4 and hetero-tetramers
[KV(1.1)2–(1.2)2, KV1.1-1.2-1.1-1.1]; the tandem linking of the
genes used an inter-subunit linker [25] derived from the
untranslated regions (UTR) of the Xenopus b-globin gene
(GenBankH accession number J00978). The cDNAs were ampli-
fied using KVX sequence-specific primers, as described [26].
Correct positioning of the genes in all of the pIRES2-EGFP
plasmid constructs was confirmed by restriction analysis and DNA
sequencing. Constructs were expressed in HEK293 cells (Amer-
ican Type Cell Culture, VA, USA) and surface biotinylation was
performed as reported [27]. Western blotting with mouse mAb for
KV1.1 or 1.2 was followed by their visualization with a goat anti-
mouse secondary antibody conjugated to horseradish peroxidase.
Macroscopic currents were measured from these cells by whole-
cell voltage clamp recordings (EPC10, HEKA Elektronik,
Germany). Patch pipettes (in-bath resistance1.5–3.0 MV) were
filled with an internal solution (in mM): 95 KF, 20 KCl, 1 CaCl2,
1 MgCl2, 11 EGTA, 10 HEPES, 2 Na2ATP (pH 7.2 with KOH).
External medium contained (in mM): 135 NaCl, 5 KCl, 2 CaCl2,
2 MgCl2 and 5 HEPES (pH 7.4 with NaOH). The liquid junction
potential was corrected and series resistance compensated (70–
80%). Conductance-voltage relationships were taken from the
averages of the steady-state currents (100 ms before the termina-
tion of 300 ms pulse stimuli) activated with voltages of 280 to
+20 mV with 5 mV increments. The activation rates were assessed
through fitting the rising phase of KV1 currents with a single
exponential function. Data were analysed by Pulsefit (HEKA
Electronik, Germany) and fitted/plotted using Igor Pro 6
(WaveMetrics, USA). The IC50 values for inhibitors were obtained
using automated whole-cell voltage clamp system (QPatch 16,
Sophion Bioscience, Ballerup, Denmark), as previously described
[26], with Qplate pin-wholes having resistances 2–3 MV. Giga-
seals were formed upon execution of a combined suction/voltage
protocol; gradually increasing suction leads to the whole cell
configuration. Blockers were applied, via a four-way pipetting
robot, through integrated glass-coated microfluidic flow channels.
Data analysis was performed using an integrated database (Oracle)
within QPatch software (Sophion Bioscience, Ballerup, Denmark).
Peptide toxins were diluted from frozen aqueous stocks into
external recording solution containing 0.01% (w/v) BSA and their
inhibitory effects determined by the Hill equation fit to 7
concentrations.
Statistical Analysis
All the data are presented as means 6 S.E.M. U-Mann-
Whitney, non-paired and paired Student’s t-test was applied for
comparison, with P,0.05 considered statistically significant.
Results
Widespread Demyelination in Axon-rich Tracts of CNS
Induced by Cuprizone
CNS demyelination was established in mice fed with cuprizone
for 8 weeks. The animals did not show overt signs of ataxia,
seizures, anorexia or other distress except that weight loss occurred
during the first 2–3 weeks. Although this was followed by a gradual
gain in weight by the end point, the treated mice remained
underweight compared to controls (,10%, n = 20, p,0.05).
Analysis of brain sections stained for myelin with CV or LFB
revealed its depletion especially notable in white matter-rich
structures such as corpus callosum, internal capsule, stripes of the
caudate nucleus and cerebellar peduncle (Fig. 1A, B). As evident
from the histogram of myelin density in corpus callosum, a
broader range of signals of higher intensity prevailed (36.760.37,
ROI = 171) in controls compared to the values pulled from
samples of cuprizone-treated mice that yielded more uniform
signal densities of lower intensities (17.960.22, ROI = 146)
(p,0.001; Fig. 1C). Cross-correlation analysis of relative myelin
densities in callosal and hippocampal CA3 regions also unveiled
prominent myelin loss in the hippocampus (Fig. 1D). Likewise,
myelin loss was prominent in the cerebellar region of experimental
group, with its substantial depletion in the paranuclear region of
deep cerebellar nuclei and peduncular structures (Fig. 1A, right
hand panels and E). These histochemical findings were corrob-
orated by quantisation of myelin content of the brain tissue, which
showed its significantly lower levels in total brain and forebrain of
cuprizone-treated mice (56.267.4% and 71.368.7% of control,
p,0.05; n = 3 in each group; not shown).
Altered Compactness of Myelin and Axonal Geometry in
ON of Cuprizone-treated Mice
Structural changes in ON axons from mice that received
cuprizone relative to the controls were analyzed at light and
electron microscopic levels. Figure 2A depicts low power
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micrographs of the toluidine blue stained cross-sections of ON.
Axonal counts were comparable in two groups over the equivalent
areas (158146658 vs. 140696955 over 50 mm2, p = 0.18). An
absence of visible myelin breakdown and spheroid blebs accords
with the lack of axonal degeneration in this model. Yet, individual
axons of treated mice appeared less annular (Fig. 2A), with an
overall reduced number of large calibre fibres (Fig. 2C, lower
inset). Increased peri-axonal space with segregation of axons into
irregular bundles along with occasionally visible reactive macro-
phage-like elements was also characteristic of the experimental
samples (Fig. 2A). At the ultra-structural level, loosely myelinated
axons with fewer lamellae were regularly encountered in the
cuprizone-treated samples whereas the controls were typically
enclosed in a compact and periodic sheath of myelin (Fig. 2B).
Quantitative analysis of the axonal geometry and comparison with
controls confirmed a notably lower fraction of large calibre axons
(D = 0.47460.02 mm vs. D = 0.43760.01 mm; p,0.001) with an
overall reduced axon cross-sectional area (Fig. 2C, upper inset).
Estimates of the relationship between myelin thickness and axon
diameter (Fig. 2D) unveiled a stronger correlation of these two
parameters in ON from mice that were fed with cuprizone
(R2 = 0.31 vs. R2 = 0.13, cuprizone-treated vs. controls), suggestive
of a greater sensitivity of the myelin sheath thickness to cuprizone
as compared to the axon diameter (Fig. 2D inset). Interestingly, the
concurrent decrease of both parameters in axons maintains the
estimated axonal ‘g’ ratio in treated samples relatively unaltered
(n = 1019 vs. n = 910; control 0.845 vs. cuprizone 0.856, p = 0.17).
Taken together, the evidence from light and electron microscopic
data confirm substantial demyelination of the ON with changes in
the morphometry of axons in the cuprizone treated mice, without
any signs of their degeneration.
KV1 Channel Distribution and Composition are Altered in
the Demyelinated ON Axons
In myelinated axons, there is a sharp segregation of voltage-
dependent ion channels at the nodes of Ranvier with NaV
channels clustered within the nodal gaps while KV1 channels are
located in the JXPs [28]. Both nodal and JXP regions were readily
identified in control ON with pan-specific NaV antibodies
delineating nodes, whilst KV1.2 reactivity was most intense
adjacent to the nodal gaps, decreased towards the internodes
and gradually diminished to background level (Fig. 3A1). Visibly
intact nodes were also detected in ON from the cuprizone-treated
mice (Fig. 3A2), albeit representing only a fraction (33.362.2%)
with the majority showing elongated KV1.2-positive JXPs
(Fig. 3A2, C). In controls, double labelling with anti-KV1.1 and
1.2 specific antibodies revealed overlapping fluorescence, with
both subunits flanking most of JXPs (Fig. 3B1). In contrast, the
level of KV1.1 and 1.2 in the mice receiving cuprizone appeared
Figure 1. Cuprizone administration to mice induces widespread demyelination in several brain structures and reduces the myelin
content. (A–B) Representative light micrographs of sagittal sections of brain from control and cuprizone-treated mice, respectively, stained for
myelin with CV and LFB dyes. (A) Myelin is visualised in samples from the control mice, as light brown by CV and dense blue for LFB, in corpus
callosum (CC), the stripes in the corpus striatum of the caudate putamen (CPu), internal capsule (IC) and the central nuclei of the cerebellar medulla
(CN). (B) Extensive demyelination was observed in the above regions of treated mice. (C) Plot of the density distribution of myelin stained with LFB of
defined colossal ROIs. A narrow and leftward-shift in the histogram of the density of myelin in cuprizone-treated samples reflects callosal
demyelination (n = 6 in each group). (D) Correlation analysis of the density of LFB-stained myelin of random ROIs from callosal and hippocampal CA3
areas. Note the higher level of callosal myelin in controls (R2 = 0.21) compared to CA3 area, with its stronger decline in experimental samples
(R2 = 0.54). (E) Summary histogram of the mean myelin density in CC and CP regions (.100 ROIs, from each group) with both areas revealing
significant loss of myelin in mice that had received cuprizone. * p,0.05.
doi:10.1371/journal.pone.0087736.g001
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increased (Fig. 3D, E), with KV1.1 subunit extending with greater
prominence into the internodes (Fig. 3B2, D and E). These
changes are readily reflected in high magnification confocal
micrographs as elongation of KV1.1 and 1.2 labelled JXPs (3A2,
B2, vs. 3A1, B1), in axons of cuprizone-treated mice and accord
with their overall larger JXP areas (KV1.1:2.460.5 mm
2 vs.
8.261 mm2 p = 0.006; KV1.2:3.860.4 vs. 8.261, p = 0.01)
(Fig. 3D, E). Importantly, the co-localization coefficient of
KV1.1/1.2 subunits within fluorescent profiles was higher in
controls (KV1.1/1.2 = 0.8660.06) compared to significantly di-
minished values in ON axons of cuprizone-treated mice (KV1.1/
1.2 = 0.2760.04), suggestive of a preferential increase in the
expression level of KV1.1 in demyelinated axons (Fig. 3F
compared to Fig. 3G). This inference is consistent with results of
quantisation of relative luminescence-intensity (ELISA) and
Western blot analysis which demonstrate considerable increase
in the expression of KV1.1 subunits in ON of cuprizone-treated
mice (Fig. S1) [29]. Finally, probing mouse ON (both Western
blotting and immuno-fluorescence) failed to detect KV1.3, 1.5 and
1.6 subunits in ON axons from both controls and cuprizone-
treated ONs except for a trace amount of KV1.4 (not shown).
Altered Electro-responsiveness and Conductivity of ON
from Cuprizone-treated Mice
CAP recordings were obtained from the proximal stump of
semi-dissected ON at physiological temperature (Fig. 4A, B inset).
In controls, stimulation of the distal end of the nerve evoked
synchronous responses, whose amplitude could be graded by
varying the stimulus strength (Fig. 4B); the threshold intensity for
CAPs ranged between 0.36 and 0.44 mA (0.3960.2; n = 6) and
saturating at stimuli between 0.9 and 1.2 mA (0.9660.4, n = 6)
(Fig. 4C). Uniform conduction of ON axons in controls was
evident from synchronous monophasic CAPs evoked by a single or
paired pulse stimuli, with absolute refractory phases ranging
between 2.0 and 2.6 ms (2.3860.2, n = 6) (Fig. 4E). The potential
reasons for discrepancies between the synchronous CAPs observed
herein and those obtained using suction electrode (Allan et al.,
2006) are given in MATERIALS AND METHODS. Analysis of
the effects of TEA (10 mM) or 4-AP (1 mM) on sub-maximal
CAPs of the intact ONs showed a significant increase in CAP
amplitude by 4-AP, but not TEA after 15–20 min exposure (7.9%;
n = 5; p.0.05 vs. 38.8%; n = 5; p,0.05) (Fig. 4D, F and G).
Notably, neither TEA nor 4-AP affected the 50% refractory phase
of CAPs (5.360.3 ms and 5.460.2 ms; p = 0.21 and p = 0.48) in
controls, with only 4-AP reducing the threshold stimulus intensity
(3.360.4; p = 0.038) for eliciting CAPs (not shown). Unlike the
controls, CAPs of ON from cuprizone-treated mice revealed a
distorted shape, with an early fast phase followed by a protracted
late component (Fig. 4B, D and E), reflecting temporal dispersion
of action potentials of axons in the demyelinated ON. Further-
more, the minimal stimulus intensity required for eliciting CAPs in
the demyelinated sample was elevated (range: 0.42 and 0.62 mA,
mean: 0.5860.3; n = 5; Fig. 4C) with the absolute refractory phase
prolonged (range: 2.8 and 3.6 ms; mean: 3.060.2, n = 5). In
demyelinated nerves, blockade of K+ channels with TEA (10 mM)
or 4-AP (1 mM) notably increased CAP amplitude (37.0%; n = 5;
p,0.05 vs. 57.7%; n = 5; p,0.05), with the effects of the TEA also
reaching statistical significance in controls (33.0%; n = 5; p,0.05)
(Fig. 4D, F and G). As observed with the controls, refractory time
for 50% recovery of CAPs (7.760.3 ms and 7.560.2 ms)
remained unaltered under both treatments while the threshold
stimulus intensity was significantly reduced (0.4760.1 mA and
0.4660.1 mA; TEA and 4-AP, respectively; n = 5 in each group;
p,0.05).
Differential Contribution of KV1.1 and KV1.2 to CAP in
Demyelinated ON
Despite the presence of KV1.1 and 1.2 subunits in normal and
demyelinated ON as demonstrated above, their relative contribu-
tion to tuning the electrogenic properties of axons therein
remained elusive. Exposure of control ON to the potent blockers
of KV1.1 and 1.2 subunits, DTXK (100 nM) or TsTX-Ka
(100 nM), respectively, caused no alterations in the characteristics
of CAPs (Fig. 5A1, B1), with both amplitude and activation
threshold remaining relatively unaltered (amplitude increase:
Figure 2. Light- and electron-microscopic analysis of ON
reveals a decrease in the compactness and loss of myelin in
the experimental mice. (A) Low power representative photomicro-
graphs of ON from control and cuprizone-treated mice (TLB stained).
Note less annular appearance of large diameter axons with a higher
degree of intrinsic parcellation of the demyelinated nerve. (B) Electron
micrographs of ON axons from control and treated mice. Along with a
large number of myelinated axons (normal) with compact myelin
sheaths consisting of several layers, axons covered with a loose myelin
envelope of only a few lamellae were regularly encountered in the
treated tissue (black arrows). (C) A summary plot of the distribution
cross-sectional area of axons with insets highlighting divergence of this
parameter for thicker axons (lower inset) and reduced mean cross-
sectional area (upper inset) of axons in treated samples. (D) Graphical
illustration of the relationship between myelin sheath thickness and
axon diameter with regression lines and summary histogram of myelin
thickness (inset) show a significant decrease in both parameters in
treated mice.
doi:10.1371/journal.pone.0087736.g002
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1567.2%, n = 5; 10.365.8%, p.0.05; n = 6, respectively)
(Fig. 5A2, B2). At the specified concentrations, DTXK is known
to block completely KV1.1-containing channels (IC50 of 2.5 nM)
[30,31] while TsTX-Ka abolishes K+ currents mediated by KV1.2
channels (IC50 of 0.55 nM) [32]. Because of the strong presence of
both subunits in mouse ON JXPs (Fig. 3A1, B1), the ineffective-
Figure 3. Demyelination alters the distribution and composition of KV1 channels in ON. Double [pan-Na (red)/KV1.2 (green)] immuno-
labelling of control (A1) and experimental (A2) ON: note elongated JXPs with alterations in most of the nodal NaV channel clusters in samples from
the cuprizone-treated mice. (B1–2) Double immuno-labelling of ON for KV1.1 (red) and KV1.2 (green) subunits of KV1 channels: control (B1) and
experimental (B2) samples, respectively. Note the highly localized occurrence of these proteins in JXPs of controls contrasting with their diffuse
location along the ON axons in demyelinated specimens. Yellow staining corresponds to JXP regions showing co-localization of these proteins. The
scale bars for low and high magnifications are 6 and 2 mm, respectively. (C) Summary histogram of the intact JXP labelled with anti-KV1.2 antibody of
control and experimental ON axons (n = 3 in each group). (D) A plot of the mean area of JXPs labelled for KV1.1 channels in control (2.460.5 mm
2)
compared to the increased area of fluorescence intensity of JXPs in demyelinated (8.261 mm2) axons. (E) The mean fluorescence area of JXPs labelled
for Kv1.2 channels in control (3.860.4) was lower than that in the treated ON axons (8.261 mm2). (F) A summary histogram of KV1.1 and 1.2 co-
localization in control (0.8660.06) and demyelinated (0.2760.04) ON demonstrating a significant (p,0.001) reduction in the degree of KV1.1/1.2 co-
localization in ON axons of the experimental mice. (G) The degree of KV1.2/1.1 co-localization in ON axons of the experimental mice showed a
reduction, which is still significant (P,0.05), when comparing the control (0.7160.06) and the demyelinated ON (0.4960.04) values. Data are taken
from control and demylinated ON axons of 3 animals, in each group.
doi:10.1371/journal.pone.0087736.g003
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ness of such toxin blockers in intact axons is likely to be due to
poor accessibility of the K+ channels. In stark contrast, in
demyelinated nerves, the same concentrations of DTXK and
TsTX-Ka caused significant augmentation of the CAP amplitude
(74.365.4%, n = 5; 32.264.2%, n = 5; respectively, p,0.05) with
the late asynchronous component being particularly enhanced
(Fig. 5A and B). Concurrently, both current thresholds (72.5%
decrease with DTXK; 22.8% decrease with TsTX-Ka; P,0.05)
and 50% refractory time were notably reduced, albeit the latter
reached statistical significance only in DTXK treated samples
(61.367.1%, n = 5 vs. 13.263.1%, n = 6; p = 0.01 and p.0.05,
respectively). The quantitatively different effects of these blockers
was unexpected given that the presence of a single toxin-sensitive
subunit renders hetero-tetrameric channels susceptible to toxins
[33], and suggests that enhanced K+ conductance in demyelinated
axons could be mediated largely, but not exclusively, through
KV1.1 homo-tetrameric channels.
KV1.1 Subunits Lower the Activation Threshold and
Speed-up Activation Kinetics of KV1 Channels
Recombinantly Expressed in Mammalian Cells
To examine how demyelination-associated enrichment of KV1
channels with KV1.1 subunit could affect their functional
properties, biophysical profiles of the currents mediated by
concatenated homo-KV(1.1)4 or KV(1.2)4 and hetero-tetramers
(KV1.1-1.2-1.1-1.1, KV1.1-1.1-1.2-1.2) were analysed. Expression
of these tetramers in mammalian HEK293 cells was confirmed by
surface biotinylation of the intact cells and Western blotting with
anti-KV1.1 or 1.2 specific antibodies. This revealed a single band
of the expected size (Mr ,250 kD) for channels expressed on the
plasmalemma (Fig. 6A), and their functionality was demonstrated
by whole cell recordings. Each mediated voltage-activated non-
inactivating K+ currents, which were consistently larger in cells
expressing KV1.2 homo-tetramers or those containing this subunit
together with KV1.1 (Fig. 6 D1-F1). Most importantly, KV1.1
Figure 4. Demyelination disrupts the conductivity of ON axons which can be partially restored by 4-AP. (A, B) A low magnification
micrograph (46) demonstrating the semi-dissected ON (ventral view) with stimulation (suction, Suc. pipette) and recording (Rec.) electrodes. Graded
synchronous CAPs recorded from control animals contrasting with bi-component CAPs derived from experimental ON activated from elevated stimuli
thresholds (C). Insert illustrates the experimental set-up for CAPs recordings. Rec. - recording electrode; Suc. - suction pipette used for stimulation. ON
– optic nerve, OX – optic xiasm. (B) Typical CAPs evoked in control ON by paired-pulse stimulation (PPS). Note the second CAP from the refractory
phase following the first CAP. The evoked CAPs recorded from cuprizone-treated (demyelinated) ON axons showed lower amplitudes and protracted
late components compared to the untreated (myelinated) ON axons. (C) Stimulus-response relation of CAPs in controls and experimental ON,
showing lower activation threshold and higher amplitudes of evoked CAPs in demyelianted ON. (D) Representative recordings of CAPs from ON of
control and cuprizone fed mice before (1) in the presence of TEA (2, upper row) or 4-AP (lower row) and (1+2) superimposed traces. (F, G) Summary of
the effects of TEA (15–20 min application) on the CAPs in control and cuprizone-treated ONs (n = 5 in each group) (E) The summary histogram of CAP
amplitudes scored before and after application of 1 mM 4-AP. Note the significant enhancement of the CAP amplitudes in demyelinated ON caused
by 4- AP (P,0.05, n = 5 in each group).
doi:10.1371/journal.pone.0087736.g004
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homo-tetrameric channels activated at less depolarized thresholds
than the currents resulting from the others (Fig. 5 D2-F2).This
feature is reflected clearly in conductance-voltage (gK-V) plot of
the K+ currents, with KV(1.1)4 activating from significantly more
hyperpolarized potentials (close to -60 mV) compared to the
KV1.1-1.2-1.1-1.1, KV1.1-1.1-1.2-1.2 and KV(1.2)4 channels (Fig. 6
D2-F2, Table 1). In all cells, the gK-V relationships of the K
+
currents were fitted well with a Boltzmann function with half-
maximal values of activation (V1/2) for KV(1.1)4 being most
negative followed by intermediate potentials for the currents
mediated by KV1.1-1.2-1.1-1.1 or KV1.1-1.1-1.2-1.2, and the
most depolarised values observed with KV(1.2)4 channels (Table 1).
Interestingly, significant differences were also observed between
activation rates of these currents at near-threshold potentials, with
KV(1.1)4 channel displaying a faster activation rate than the others
(Fig. 6 B and C, D inset; Table 1).
KV1.1- and KV1.2-containing Channels can be
Distinguished by Selective Blockers
HEK293 cells expressing channels composed of homomeric
KV(1.1)4, (1.2)4 or heteromeric combinations of both subunits
[KV1.1-1.2-1.1-1.1 and [KV(1.1)2-KV(1.2)2] were used to mimic
those possibly present in demyelinated ON axons. DTXK potently
and selectively inhibited only the KV1.1 homo-tetrameric chan-
nels, with sub-nanomolar IC50 (Table 2); introduction of a single
KV1.2 subunit into the tetramer (KV1.1-1.2-1.1-1.1) lowered its
susceptibility to blockade by DTXK. Having two copies of KV1.2
and KV1.1 subunits in the concatamer (KV1.1-1.1-1.2-1.2),
resulted in an even lower sensitivity to DTXK (IC50.100 nM).
On the other hand, KV(1.2)4 channel was blocked by TsTX-Ka
but apparently insensitive to DTXK (Table 2). The K
+ current
elicited by a heteromeric channel with equal numbers of KV1.1
and 1.2 subunits proved ,6 -fold less sensitive to TsTX-Ka than
KV(1.2)4. Furthermore, TsTX-Ka failed to block KV1 channels
containing 3 or 4 copies of KV1.1 subunits. Collectively, these
results showed that DTXK and TsTX-Ka are potent inhibitors of
K+ currents mediated by KV1 channels that contain at least three
copies of KV1.1 or two copies of 1.2 subunits, respectively.
Discussion
The pervasive correlation between inflammatory optic neurop-
athies and symptoms of clinical MS, manifested by disruptions of
visual functions, renders the ON an attractive experimental model.
Being an anatomical extension of the forebrain [34], ON share key
features of central myelinated tracts under healthy and disease
conditions. Herein, a substantial demyelination with reduction of
the myelin compactness and shrinkage of thick axons were
demonstrated in ON from cuprizone-fed mice. Although the
majority of nodes enriched with Na+ channels remained relatively
intact, most of the JXPs became elongated due to spread and
ectopic appearance of K+ channels composed of KV1.1 and 1.2
subunits in the inter-nodes, albeit with a disproportionate increase
in the level of KV1.1. This inquisitive observation accords with the
functional data from CAP recordings which highlighted better
restoration of ON conductivity with DTXK-(KV1.1-selective)
compared to TsTX-Ka (KV1.2-selective). Assessment of the K
+
current mediated by recombinant (KV1.1)4 homo-tetrameric
channels in HEK293 cells revealed a lower activation threshold
and faster kinetics than those recorded for (KV1.2)4 homo-
tetramers or KV1.2 subunit-containing hetero-tetramers. Thus,
along with the demonstration of myelin loss and a decrease in the
axon diameter, our data also provide important insights into
demyelination-related changes in the molecular composition of
KV1 channels in central axons, which could be of potential
relevance to MS and other disease associated with the loss of
myelin.
ON Demyelination in Cuprizone-treated Mice: Relevance
to MS
Models of virally- or chemically-induced (including by cupri-
zone) demyelination and experimental autoimmune-allergic en-
cephalomyelitis have been widely used for studying de- and re-
myelination processes in the CNS [35,36]. High reproducibility
with scattered lesions in the white matter, accompanied by edema
and astrogliosis caused by cuprizone closely mimic changes
occurring in the CNS during MS [37,38]. Although some brain
regions seem to be more sensitive to cuprizone than others, the
Figure 5. A more promenant contribution of KV1.1 than 1.2 subunits of Kv channels in regulating the excitability and conductivity
of demyelinated ON. (A1, B1) Representative CAP recordings demonstrating the effects of DTXK and TsTX-Ka respectively, before (1) and 40 min
after presentation of the toxins to the control and experimental ONs (2). (A2, B2) Time course of the effects of DTXK and TsTX-Ka, respectively, on
evoked CAPs (sub-maximal) of control (filled circle; n = 5; n = 6) and experimental (open circle; n = 5; n = 5), respectively. Black arrows indicate the start
of the application of toxins. Note a slight increase in the CAPs by these toxin blockers in controls (A1, B1, filled circle) compared to much stronger
enhancement of CAPs in demyelinated ON by TsTX-Ka (B1 and B2) and especially DTXK (A1 and A2).
doi:10.1371/journal.pone.0087736.g005
Ectopic KV1.1 Channel in Demyelinated Optic Nerve
PLOS ONE | www.plosone.org 8 February 2014 | Volume 9 | Issue 2 | e87736
widespread CNS demyelination involving corpus callosum,
hippocampus, cerebellum, basal ganglia and other white matter
rich brain structures have been documented [38,39,40]. In
addition to reduced myelin content of the forebrain and
cerebellum, we demonstrate for the first time pronounced myelin
depletion of the ON in mice fed cuprizone. Indeed, electron
microscopic analysis highlights reduction in the myelin thickness
and compactness, along with shrinkage of the large diameter axons
associated with the emergence of loose myelin stacks and sub-
axolemmal vacuolar elements. A complete lack of myelin
breakdown or axonal spheroid blebs in our experimental samples
accord with an absence of degeneration of axons and neurons
reported for this model [40]. Similar signs of axonopathy with
reduction in the axonal caliber followed by degeneration at the
later stages have been reported for transgenic mice lacking myelin
proteins such as 29,39cyclic nucleotide 39-phosphodiesterase,
proteolipid protein and myelin-associated glycoprotein [41,42] as
well as in autopsies from MS brain [37]. These changes in axonal
ultra-structure have been attributed to the fact that oligodendro-
cytes and myelin integrity, in addition to providing insulation,
supply trophic support to axons which is essential for stability and
normal functionality [43,44]. Interestingly, the decrease in the
myelin thickness of axons in our model was associated with
moderate reduction of their diameter, perhaps a compensatory
Figure 6. Functional characterization of recombinant KV1.1 homo-tetramers reveals distinctive biophysical profiles from those of
KV1.1/1.2 heteromers. (A) Western blots of surface expressed concatenated KV1 channels in[HEK293 cells. Lanes: 1, non-transfected cells show no
immuno-reactivity for KV1.1 (or KV1.2, not shown); 2, KV(1.1)4 and 3, KV1.1-1.1-1.2-1.1 detected with anti-KV1.1 IgG giving a band size of ,250 kD; 4
and 6, KV(1.2)4 homo-tetramer was non-reactive with anti-KV1.1 IgG (4) but gave a distinct band when probed with KV1.2 IgG (6). Protein markers are
indicated in lanes 5 and 7. (B, D1–F1) Representative recordings of macroscopic currents (300 ms pulse) from HEK293 cells transfected with the
individual recombinant channels. (B, C) Activation rate of the voltage-dependent K+ currents mediated by KV(1.1)4 (left) and KV(1.2)4 (middle)
channels (within the range of 10–30% of max. current) at 5 mV from indicated voltages (below) with super-imposed (right) representative traces
from. A notable difference between the rates of activation of KV(1.1)4 and KV(1.2)4 is revealed by fitting the data with a single exponential (see C).
(D2–F2) Conductance-voltage relations of macroscopic currents measured, based on the K+ current of the last 100 ms for each channel.
Conductance at various command potentials were normalised and fitted with a single Boltzmann function. The difference in conductance values of
KV(1.1)4 and KV(1.2)4 channel were statistically significant from 255 mV (P,0.05, Mann-Whitney U-test, see Table 1 for summary of the biophysical
data).
doi:10.1371/journal.pone.0087736.g006
Table 1. VK for activation and onset rate of currents







V1/2 (mV) 23561(6) **22061(10)
#**21761(9) **2761(8)
tau1/2 (ms) 1362(6) *1861(8) **2461(8) **2962(8)
Results are represented as means 6S.E.M. (n-values);
*(p,0.05) and ** (p,0.005) numbers are significant compared to those from
KV(1.1)4, (Mann Whitney U-test);
#data are taken from Al-Sabi et al., (2010).
doi:10.1371/journal.pone.0087736.t001
Table 2. Differential inhibition of concatenated KV1 channels
expressed in HEK293 cells by DTXK and TsTX-Ka.
IC50 (nM) DTXK TsTX-Ka
KV(1.1)4 0.2760.07 (5) .100 (3)
#
KV1.1-1.2-1.1-1.1 *460.1 (4) .100 (3)
KV1.1-1.2-1.2-1.2 .100 (4) 1562 (4)
#
KV(1.2)4 .100 (3) 2.660.2 (3)
#
Results are represented as means 6S.E.M.; n-values are in brackets;
*(p,0.05) numbers are significant compared to KV(1.1)4 (t-test),
#Data were taken from Al-Sabi et al., (2010).
doi:10.1371/journal.pone.0087736.t002
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process, which retained the ‘g-ratio’ fairly normal. In fact, smaller
axon diameter would reduce the capacitative load, favouring more
effective propagation of action potentials through demyelinated
segments; also, it would assist in maintaining ion homeostasis,
delaying the onset of irreversible degeneration and neurological
decline [45,46]. It should be emphasized that even though the
extent to which cuprizone demyelination reflects MS pathology in
humans remains disputable [38,39], extensive breakdown of
myelin with its depletion in ON documented herein suggest this
model as being useful and appropriate for exploring certain
aspects of MS patho-biology.
Functional Impact of Aberrant KV1 Channels in
Demyelinated Axons
Even though clustering of Na+ channels in axons does not
require the myelination process and developmentally precedes it,
their lateral diffusion during demyelination suggests a stabilizing
influence of axo-glial signalling on nodal Na+ channel clusters
[47,48]. In contrast, the myelin integrity appears to be mandatory
for targeting K+ channels to JXPs [28,49]. Accordingly, although
antibodies to KV1.1 and 1.2 subunit labelled numerous JXPs in
cuprizone-treated mice, many of these specializations were greatly
elongated with KV1 proteins present in internodes, consistent with
earlier documented dislocation of axonal K+ channels from their
canonical sites in demyelination animal models and MS brain
[49,50]. Curiously, these changes in the distribution of KV1
channels appear to be associated with alterations of their
molecular constituents, with co-localization analysis indicating
disproportionate gain in KV1.1 immuno-reactivity with a notable
advancement into the internodes of the demyelinated axons. In
light of the established co-assembly of KV1.1 and 1.2 at JXPs
throughout the brain [31,49], preferential increase in the content
of KV1.1 expression in the experimental mice suggests de-novo
synthesis and post-translational enrichment of KV1 channels with
this protein and, perhaps, expression of KV1.1 homo-tetramers.
Notably, an asymmetric gain in the level of KV1.1 under
demyelination has been demonstrated indirectly by in situ
hybridization studies on shiverer mice. Affected by deletion of the
59 exons of a gene encoding myelin basic protein, this model
revealed much greater elevation in the level of KV1.1 transcripts
(compared with KV1.2) [51]. Thus, along with stabilizing KV1
channels at JXPs, our data implicate an important role of axo-glial
interactions in regulating their subunit composition. It is worth
stressing that the occurrence of KV1.1 in the absence of other
members of KV1 family has also been revealed in a minority of
healthy peripheral axons but yet of unknown functionality [52].
Concurrently, electrophysiological data demonstrate partial
restoration of CAPs and shortening of the refractive phase in
demyelinated ON by KV1 channel blockers. Unlike CAPs in
controls that are sensitive to 4-AP, in ON from mice treated with
cuprizone, both TEA and 4-AP enhanced the population
response. Nodal location of channels sensitive to 4-AP but not
TEA may explain the discrepancy between the effects of these
blockers. Such an interpretation is consistent with earlier studies,
which demonstrated two pharmacologically-distinct K+ channel
types, TEA and 4-AP-sensitive, in adult ON [53]. Because 4-AP
(but not TEA) is able to diffuse through biological membranes
[54], it could also act as an internal blocker of channels located in
paranodal and internodal segments of healthy axons, another
possible explanation of the differences between their effects.
Interestingly, our data contrast with those from sciatic nerve where
CAPs are insensitive to these blockers prior to and after their
demyelination (Bostock et al., 1981). While improved conductivity
of ON by 4-AP accords with its beneficial effects documented in
MS clinical trials [12,55], the broad spectrum of actions including
pro-convulsive effects hinder its widespread use for MS therapy.
Similar electrophysiological experiments with DTXK and TsTX-
Ka as KV1 channel blockers revealed the former be more effective
in restoring CAPs in demyeliated axoms. It is worth stressing that
in demyelinated samples these toxin blockers enhanced primarily
the asynchronous late phase of CAPs, an effect attributable to their
preferential action on slow conducting with compromised axon
myelin sheath and enriched with ectopic KV1 channels accessible
to these peptides. Because the relative strengths of K+ and Na+
currents in axons is a primary determinant of successful
propagation of action potentials [9], the greater rescue of ON
functions by DTXK accords with enrichment of demyelinated
axons with KV1.1-containing heteromers or homo-tetrameric
KV1.1 channels.
Implications for MS and other Demyelinating Disorders
of the Central Nervous System
A well-established molecular mechanism for stabilizing the
membrane potential of demyelinated axons is provided by Na+/
K+ ATPase which, due to its electrogenic nature, provides a
persistent hyperpolarizing drive during sustained activity, moving
the axonal membrane potential away from the firing threshold
[56]. An over-expression of K+ channels enriched with KV1.1
subunits in the ON axons from cuprizone-fed mice provides
another, perhaps, equally powerful means for stabilizing the
membrane potential at sub-threshold voltages. Unlike genetic
knock-down of KV1.2 subunit (the main partner of KV1.1)
associated with reduced excitability of central neurons [57], KV1.1
null mutants exhibit hyper-excitability and augmented axonal
conductivity [6,58], suggesting a powerful dampening influence of
KV1.1-chonating channels on neuronal responsiveness. Indeed,
the faster activation from more negative potentials of the K+
current mediated by Kv1.1 subunit-dominated channels in HEK
293 cells could restrain and stabilize the axonal membrane at sub-
threshold potentials. Considering the selective increase and ectopic
expression of KV1.1 subunit in axons of demyelinated ON in
relation to restoration of conductivity by DTXK point to this being
a potential target for ameliorative interventions. The sparse
information available on specific molecular alterations responsible
for impaired conductivity of demyelinated axons along with the
poor selectivity of small KV channel blockers with their
considerable adverse effects have greatly hampered the develop-
ment of effective restorative means. Interference of 4-AP, one of
the most promising candidates, with remyelination and regener-
ation of impaired oligodendrocytes [59] renders its clinical use for
rescuing axonal conductivity problematic; this stresses the urgent
need for identification and evaluation of novel drug candidates.
Hence, the recognition herein of novel KV1 channels enriched
with KV1.1 subunit represent a significant step forward towards
the development of a specific extra-cellular blocker of such
channels with potential for recovering the conductivity of
demyelinated axons. Nevertheless, research on human specimens
is warranted to ascertain if the demyelination-associated changes
in the composition of KV1 channels described herein is applies to
central axons affected by MS.
Supporting Information
Figure S1 (A, B) Quantification of the KV1.1 and KV1.2 a
subunits in detergent-solubilized extracts of optic nerve, using
Western blot (WB) analysis (A) and chemiluminisence ELISA (B).
(A) Representative blots of KV1.1 and KV1.2 subunits of KV1
channel from mouse optic nerve. Mouse monoclonal IgGs for
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KV1.1 and 1.2 were used for detecting the protein (bands) of
interest. The positions of markers shown on the left side indicate
the molecular weight (kD). For Western blotting 15 mg crude
membrane protein was loaded on each track of the gel. Note
considerably denser KV1.1 band for material from cuprizone-
treated mice. (B) ELISA based quantification of KV1.1 subunit
protein shows significant increase of its level in an extract of optic
nerve from cuprizone-treated mice (p,0.05; paired Student’s t-
test). The signals were quantified as relative luminescence
intensity; the relative values for untreated control and cuprizone-
treated sample derived from the known standards are presented
(for further details, Bagchi, 2013).
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